CJC 1295 No DAC 10mg is a peptide analogue of growth hormone releasing hormone GHRH. It is used in laboratory research to observe how
growth hormone release is regulated through receptor activity. This version does not include DAC modified extensions, which means it is studied for shorter acting interaction with the GHRH receptor.
Often referred to as mod GRF 1-29, this peptide is linked to growth hormone secretion through natural signalling pathways. It is commonly discussed alongside compounds such as CJC-1295 No DAC Ipamorelin, where different receptor systems are studied together.
In controlled environments, it is used to observe how the body may stimulate GH through interaction with the GHRH receptor, while also looking at how ghrelin receptor pathways contribute to overall growth hormone release.
How It Works
CJC-1295 No DAC works by mimicking the body’s natural growth hormone releasing hormone. It binds to the GHRH receptor and supports signalling that can lead to growth hormone release.
This process is linked to:
- Growth hormone secretion
- GHRH receptor activity
- Natural growth hormone signalling
- Regulation of GH release
Because it does not include a DAC modified structure, it is typically used to observe shorter, more controlled pulses of growth hormone release rather than extended activity.
This distinction is important in models where timing and frequency of growth hormone secretion are being studied.
Where It Fits
This peptide is often used in research that look at
how growth hormone is released in response to specific signals. It is also included in setups where lean muscle mass and fat loss are being observed in relation to growth hormone activity.
It is sometimes compared with longer acting versions of CJC-1295, as well as combinations such as CJC-1295 No DAC Ipamorelin. In these cases, researchers look at how GHRH receptor activity and ghrelin receptor pathways work together.
Because of its shorter action, it is commonly used in studies where precise control of growth hormone release is required.
What’s Being Observed
Work involving this compound often focuses on how growth hormone secretion responds to controlled stimulation. This includes observing how GH release changes based on timing, dosage, and interaction with other pathways.
Common areas of interest include:
- Growth hormone release patterns
- GHRH receptor interaction
- Response of ghrelin receptor pathways
- Changes in lean muscle mass under controlled conditions
- Fat loss linked to growth hormone activity
These models are used to better understand how the body regulates natural growth hormone and how different signals influence that process.
Research Context
CJC-1295 No DAC is used in laboratory research that focuses on growth hormone pathways and endocrine signalling. It is particularly relevant in models that look at growth hormone deficiency and how GH release can be stimulated through receptor activity.
Because it acts as a growth hormone secretagogue, it is used to study how the body can be prompted to release its own growth hormone. In simple terms, a growth hormone secretagogue is a rather than supplying it directly.
This also includes observing how growth hormone secretion interacts with other systems involved in metabolism, recovery, and structural changes over time.
All work is carried out in controlled environments and is limited to laboratory research.
Side Effects And Limitations
Information on side effects is limited. Most available data focuses on how the compound influences growth hormone release rather than long term outcomes.
Because it interacts with endocrine pathways, responses may vary depending on the conditions used in each model.
Long term effects are not fully established, and results may differ depending on study design and setup.
Format And Handling
The CJC 1295 No DAC 10mg vial is supplied as a lyophilised powder. This format supports stability during storage and transport.
Reconstitution is required prior to use, typically using bacteriostatic water. Once prepared, solutions should be handled using standard laboratory procedures.
This includes maintaining stable temperatures and avoiding repeated freeze and thaw cycles to preserve peptide integrity.
This format allows flexibility in how the compound is used, particularly in models where timing and dosing need to be adjusted.
Disclaimer: This product is sold strictly for research purposes only. Not for human consumption. 
